Article
Genetic factors associated with response to intravitreal ranibizumab in Korean patients with neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) - 1 Feb 2014
Park Un Chul, Shin Joo Young, Kim Sang Jin, Shin Eun Soon, Lee Jong Eun, McCarthy Linda C, Newcombe Paul J, Xu Chun-Fang, Chung Hum, Yu Hyeong Gon
Abstract excerpt
PURPOSE: To investigate the association between genetic risk variants for age-related macular degeneration (AMD) and response to intravitreal ranibizumab in Korean patients with neovascular AMD. METHODS: This prospective study included 273 treatment-naive patients (273 eyes) who underwent 5 monthly injections (Months 0, 1, 2, 3, and 4) of intravitreal ranibizumab for neovascular AMD. Patients were genotyped for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
